Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2009-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety of the PET-512MC Transesophageal Transducer
NCT01186380
Implementing Myocardial Computed Tomographic Perfusion in a Community Hospital Setting
NCT02756234
Multi-organ Transit Time Acquisition Using Contrast Ultrasound
NCT05135169
Evaluation of Modified Bite-Block for Invasive Imaging Procedures
NCT04236297
Pilot Safety Study to Determine the Ability of the Protector Cap Jet Injector to Prevent Cross-Contamination
NCT00219453
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The objective of the study is to demonstrate the safe use of the redesigned Toshibal TEE transducer for ease of passage and during transitioning into and down the esophagus to complete a normal TEE study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TEE Procedure
Patients who have been scheduled for a TEE procedure by their physician
PET-511BTM
Transesophageal Transducer
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PET-511BTM
Transesophageal Transducer
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Informed consent understood and signed
* Compliance with post-treatment follow-up protocol requirements
Exclusion Criteria
20 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Toshiba America Medical Systems, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Toshiba America Medical Systems, Inc.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gregory B. Clarke, M.D
Role: PRINCIPAL_INVESTIGATOR
The Christ Hospital
David Rubensen, M.D.
Role: PRINCIPAL_INVESTIGATOR
Scripps Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Scripps Health
La Jolla, California, United States
The Christ Hospital
Cincinnati, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TEE-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.